Arcview Collective Fund ("The Collective"), formerly Viridian Members Fund invests in seed, early-stage and opportunities in companies with high-growth potential in the cannabis industry. The Collective invests across subsectors where it leverages its members’ expertise, to make investments averaging $50,000 to $250,000, each, over the life of the investment.
The Arcview Collective Fund is a member-managed venture fund. This is a hybrid model between an angel group and a traditional venture fund. The members of the fund range from experienced angel investors and partners in VC funds to executives of successful companies.
Our members bring their expertise to the table and can actively participate as much as they like in the fund's investment process. Members are also given the opportunity to make additional investments alongside the fund.
Sub Sector Focus
Initial focus on the following subsectors of the cannabis industry: Agriculture Technology, Biotechnology & Pharmaceuticals, Software Media & Analytics, Cultivation & Retail, Infused Products and Extracts, and Miscellaneous Ancillary Products & Services
The fund has a primary focus on the United States, although companies in Israel and Canada are considered.
The Fund will mostly invest in seed, and early-stage companies that have proof of concept, are revenue positive or have generated insightful user metrics. The Fund will also invest in select later-stage companies and special situations.
Unlike a standard venture fund, the General Partnership is owned by the investors.
The Membership makes investment decisions, pursuant to a committee structure. Committees are set up to handle the business of the fund. An Executive Committee is comprised of volunteers from the Membership and provides oversight of the Arcview Collective Fund.
Investment opportunities are introduced to The Collective by founders, members, affiliated organizations, fund managers and other institutions. Deals may also be submitted through our website here. Submitting companies are requested to submit a presentation and complete the intake questions.
The Evaluation Committee members review investment opportunities, and if the Evaluation Committee elects to have a company present to the Membership, it will help the company prepare for the presentation.
A Due Diligence Committee is established for each portfolio company approved by the Membership for due diligence. Each Due Diligence Committee will make a recommendation to the Membership who will then vote to make an investment in the Company or pass.
Following an investment, a Monitoring Committee is established for each portfolio company, often including members of the Due Diligence Committee, to work with the portfolio company and report on the company at meetings of the Membership. The committee is responsible for keeping the fund members updated on the portfolio company’s material developments, including management changes, subsequent rounds of venture investments and the company's business milestones.
Altopa, Inc. has pioneered the first consumer device capable of precision blending essential oils, dietary supplements, and other botanical extracts for use in home health and wellness applications.
NorCal Cannabis Company
NorCal Cannabis Company plans to integrate a diverse range of industry segments with fresh insights into the underlying economics of California cannabis.
33 Brands, LLC
mood33 was created by people seeking smoke-free cannabis experiences to enhance their diverse lifestyles and consumption preferences.
UbiQD's quantum dots are very effective at absorbing a broad spectrum of light and converting that energy into emitted light of a single color that we tune by controlling size. Tuning the size and composition of the dots is achieved by carefully adjusting manufacturing conditions.
Fleur Marche, Inc
TThe Company is an online Cannabis apothecary offering a wide range of products and information.
Garden Society has been created for the canna-curious woman looking to indulge in an effortless cannabis experience without having to think about the science behind it.
Jeffrey Finkle, CEO Arcview Ventures
Jeanne Sullivan, CIO Arcview Ventures
Joe Rubin - ARC Angel Fund
Mike Kelly - Merion Partners
Ed Reitler - Reitler Kailas & Rosenblatt
Scott Rosenblatt - Reitler Kailas & Rosenblatt
Scott Greiper - President, Viridian Capital Advisors
Troy Dayton, Co-Founder, The Arcview Group
Ari Hoffnung, CEO, Vireo Health
Peter McDonough, Former President Diageo N.A.
Zachary Rapp, Co-Founder, & CEO, Sigma Genetics
Samir Chokshi, Chairman, Executive Committee
Jennifer Simonian, Former Blackrock, Winky Lux
Sandy Wollman, Co-founder Westchester Angels
Scott Coleridge, Co-Chairman, Evaluation Committee
Doron Greenberg, Co-Chairman, Evaluation Committee
Sarah Babineau, Human Resources Professional
Mary Caracappa, MD, Morgan Stanley, Angel Investor
Samir Chokshi, Managing Partner, CIO, Magara Capital
John Cococcia, Venture Partner, Armory Sq. Ventures
Scott Coleridge, Private Equity Investor
Gopa Dobson, Investor Relations, The Arcview Group
David Dussault, CEO, P1 Ind., Upstate Venture Connect, ARC Fund
Jeffrey Finkle, CEO Arcview Ventures
Corey Friedman, Online Media and Licensing Executive
Michael Gibbons, Former CFO, Wilber Ross Funds
Doron Greenberg, Spearflower LLC
Scott Greiper, President, Viridian Capital Advisors
Jeff Guberman, CEO McVeigh Inc., Angel Investor 38 Members
Gary Hochstadt, Principal Engineer, Raytheon Corporation
Mary Hochstadt, Speech Specialist, Wayland School District
Toan Huynh, Cloud Sherpa, 37 Angels, ARC Angel Fund
Mary Isaac, Entrepreneur, Angel Investor, Activist
David Issacs, Angel Investor, ARC Angel Fund
Robin Jacobs Freschman, Former CEO, Fashinvest, ARC Angel Fund
Richard Kamzan, Real Estate Investor
Chris Kelly, Chairman, POMCO, ARC Angel Fund
Evan Kushner, Kusner & Marano, P.C.
Brian Kwait, Private Investor
Jason Kwait, Private Investor
Kevin McGovern, McGovern Capital
Mark Melnyk, Angel Investor
Margaret Morrison, Americas Leader Business Dev, E&Y
Dan Moskowitz, Angel Investor
Istvan Nadas, Dunes Point Capital
Daniel Osman, King Ventures
Chris Peck, Senior Partner, Alera Group, Angel Investor
Alex Peselman, Mission Capital Group
Jennifer Prio, Investor
David Rothstein, CEO, RTi Research
Jonathan Schorr, Tax Attorney
James Sidford, Member, Deer Valley Ventures, LLC, Private Investor
Jennifer Simonian, Ex-Blackrock, VP of Finance, Winky Lux
Benjamin Thompson, Attorney
Elizabeth Wald, Investor
Bill Weinberg, CEO, Bill Win Development, Angel Investor
Sanford Wollman, Co-founder, Westchester Angels
Jeffrey Zink, Growth Advisor, Westchester Angels